Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Resignation or removal of directors other than as a result of disagreement or removal for cause.

The Board of Directors of Verastem, Inc. (the "Company") accepted the resignations of Stephen Kraus, on November 21, 2012, and Ansbert Gadicke, M.D., on November 26, 2012, from their positions as members of the Company's Board of Directors.

(d) Election of Director.

November 26, 2012, the Board of Directors of the Company unanimously voted to elect Alison Lawton, 51, and Michael Kauffman, M.D., Ph.D., 49, as directors of the Company. Ms. Lawton is expected to serve as a member of the Company's Nominating and Corporate Governance Committee. Mr. Kauffman is expected to serve as a member of the Company's Compensation Committee.

In connection with their election as directors, Ms. Lawton and Mr. Kauffman each received a stock option grant of 25,000 shares of the Company's common stock. Consistent with the Company's director compensation policy, Ms. Lawton and Mr. Kauffman will be eligible to receive certain annual cash retainer fees and an annual stock option grant of 12,500 shares of common stock. Ms. Lawton and Mr. Kauffman entered into customary indemnification agreements with the Company.

A press release announcing Ms. Lawton's and Mr. Kauffman's appointment is filed as Exhibit 99.1 hereto.

---